NCT06362993

Brief Summary

This study is designed to test the feasibility of two intervention on promoting early screening for breast cancer in rural Ghana. In one intervention, screening for breast cancer, diabetes and hypertension will be offered together. In another intervention, a series of sessions with men will be conducted with a goal to change gender attitudes and increase support to women. The investigators' long-term goal is to test these interventions in a large-scale randomized controlled trial. The specific aims of this feasibility study are to: 1) refine the study materials, including the curriculum for the sessions with men, by consulting with an expert advisory committee and a local committee, and 2) determine the feasibility of the two interventions in four clinic zones in Yilo-Krobo district in eastern Ghana (1 clinic in control, 1 clinic in the first intervention, and 2 in the second intervention). This trial registration is for the second specific aim.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

August 18, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

December 2, 2025

Status Verified

November 1, 2025

Enrollment Period

7 months

First QC Date

April 9, 2024

Last Update Submit

November 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical breast exam (CBE) utilization at the local clinic

    The outcome will be measured by asking participants, at endline, if they sought clinical breast exam at their local clinic during the 6-month study period. This information will be verified at the clinic level using Participation Cards, which will be provided to participants at the beginning of the 6-month period. Participants will be asked to bring the Card to the clinic when they come for screening.

    6 months. Outcome is measured at endline survey at the end of the 6-month period.

Study Arms (3)

Control

NO INTERVENTION

Women in this arm receive education on breast cancer and are offered clinical breast exam free of charge at their local clinic for 6 months following the education session.

Bundling

EXPERIMENTAL

Women in this arm receive education on breast cancer, diabetes, and hypertension, and are offered clinical breast exam and screening for diabetes and hypertension free of charge at their local clinic for 6 months following the education session.

Other: Bundling

Male Engagement in Gender and Health (MEGH)

EXPERIMENTAL

Women in this arm receive education on breast cancer and are offered clinical breast exam free of charge at their local clinic for 6 months following the education session. In addition, women are requested to invite their male partners to attend the breast cancer education session and 7 weekly discussion group sessions (5 men-only and 2 with women). The discussion sessions aim to enable men to change gender attitudes and behaviors that deter women's healthcare utilization.

Other: MEGH

Interventions

Education on and screening for diabetes and hypertension offered together with education and screening for breast cancer.

Bundling
MEGHOTHER

Education on breast cancer and discussion sessions to male partners to change men's gender attitudes and behaviors.

Male Engagement in Gender and Health (MEGH)

Eligibility Criteria

Age20 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥20 years. The age cutoff reflects early onset of BC in Ghana and the government's guidelines on screening.

You may not qualify if:

  • ever clinically diagnosed with a case of breast cancer, as the study's aim is to reach women who would normally not visit or have experience with the health system with regard to breast cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ghana

Accra, Ghana

Location

Study Officials

  • Nancy Luke, Ph.D.

    The Pennsylvania State University

    STUDY CHAIR
  • Adriana Biney, Ph.D.

    University of Ghana, Regional Institute for Population Studies

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 9, 2024

First Posted

April 12, 2024

Study Start

August 18, 2024

Primary Completion

March 15, 2025

Study Completion

March 1, 2026

Last Updated

December 2, 2025

Record last verified: 2025-11

Locations